======= RILP ======= == Gene Information == * **Official Symbol**: RILP * **Official Name**: Rab interacting lysosomal protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=83547|83547]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96NA2|Q96NA2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RILP&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RILP|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607848|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a lysosomal protein that interacts with RAB7, a small GTPase that controls transport to endocytic degradative compartments. Studies using mutant forms of the two proteins suggest that this protein represents a downstream effector for RAB7, and both proteins act together in the regulation of late endocytic traffic. A unique region of this protein has also been shown to be involved in the regulation of lysosomal morphology. [provided by RefSeq, Sep 2011]. * **UniProt Summary**: Rab effector playing a role in late endocytic transport to degradative compartments. Involved in the regulation of lysosomal morphology and distribution. Induces recruitment of dynein-dynactin motor complexes to Rab7A-containing late endosome and lysosome compartments. Promotes centripetal migration of phagosomes and the fusion of phagosomes with the late endosomes and lysosomes. {ECO:0000269|PubMed:11179213, ECO:0000269|PubMed:11696325, ECO:0000269|PubMed:12944476, ECO:0000269|PubMed:14668488}. |Jnk-SapK ap N| |RILP| |intralumenal vesicle formation| |regulation of multivesicular body size| |regulation of endosome size| |early endosome to late endosome transport| |small GTPase binding| |vesicle-mediated transport between endosomal compartments| |endosome transport via multivesicular body sorting pathway| |dynein light intermediate chain binding| |multivesicular body sorting pathway| |endosome to lysosome transport| |phagocytic vesicle membrane| |endosome organization| |vesicle budding from membrane| |antigen processing and presentation of exogenous peptide antigen via MHC class II| |antigen processing and presentation of peptide antigen via MHC class II| |antigen processing and presentation of peptide or polysaccharide antigen via MHC class II| |lysosomal transport| |late endosome membrane| |late endosome| |negative regulation of protein catabolic process| |ciliary basal body| |vacuolar transport| |cytosolic transport| |Rab GTPase binding| |protein dimerization activity| |antigen processing and presentation of exogenous peptide antigen| |antigen processing and presentation of exogenous antigen| |antigen processing and presentation of peptide antigen| |antigen processing and presentation| |positive regulation of protein catabolic process| |endosomal transport| |lysosome| |vesicle organization| |lysosomal membrane| |negative regulation of catabolic process| |cilium assembly| |cilium organization| |regulation of cellular component size| |regulation of protein catabolic process| |endomembrane system organization| |positive regulation of catabolic process| |plasma membrane bounded cell projection assembly| |cell projection assembly| |regulation of anatomical structure size| |protein-containing complex| |organelle assembly| |membrane organization| |regulation of catabolic process| |negative regulation of protein metabolic process| |plasma membrane bounded cell projection organization| |cell projection organization| |protein transport| |intracellular transport| |peptide transport| |amide transport| |establishment of protein localization| |positive regulation of protein metabolic process| |establishment of localization in cell| |nitrogen compound transport| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|1.82| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|2.01| |[[:results:exp18|Doxycycline 10μM R00 exp18]]|2.62| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5797 * **Expression level (log2 read counts)**: 1.3 {{:chemogenomics:nalm6 dist.png?nolink |}}